ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Is It Ever Too Soon To Start Your Extractables And Leachables Assessment?

  Learn what you need to know about planning for your extractables and leachables testing programs to mitigate delays to your drug development timelines.

• Sophisticated Formulation Approaches For Insoluble Drug Candidates

  A sophisticated drug delivery approach involves collaboration, technical experience, and years of working knowledge in drug development at different stages of the process.

• Key Considerations For Selecting Flexible Fillers

  Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.

• Increasing Bioavailability With Amorphous Solid Dosage Formulations

  Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

• Deploying A Circular Economy For Medical Devices

  A circular economy prioritizes sustainability throughout the supply chain by eliminating waste, circulating products and materials, and regenerating nature.

• Prioritize Safety And Mitigate Risk In HPAPI Manufacturing

  As highly potent active pharmaceutical ingredients become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality.

• Strategies For Accelerating The Development Of Modified Release Oral Forms

  Careful selection of appropriate excipients and delivery technologies is key to the design of modified release (MR) formulations fulfilling specific performance requirements.

• Selecting A Vial Container Closure System With The DeltaCube™ Modeling Platform

  Understand a system approach that facilitates data-driven selection and optimization of vial container closure system components.

• Your Approach To USP <382> For Your Drug Product Packaging

  The USP requirements for elastomeric components of container closure systems used for parenteral products are changing. Explore the implications for vial, syringe, and cartridge container closure systems.

• Streamlining Primary Container And Device Selection With Predictive Calculations

  Expolore a theoretical approach to complement experimental approaches to more quickly select a packaging and delivery system for your drug product.